Central opiate modulation of growth hormone and insulin-like growth factor-I

Yojiro Hashiguchi, Patricia E. Molina, Jie Fan, Charles H. Lang, Naji N. Abumrad

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The effects of central administration of morphine-sulfate (MOR:80 μg) and morphine-6-glucuronide (M6G:1 μg) on the growth hormone (GH)/insulin-like growth factor (IGF) system were assessed. MOR and M6G were injected intracerebroventricularly (ICV) in chronically catheterized 24 h fasted rats; time-matched control animals received H2O (5 μl). MOR increased plasma GH concentrations 3-fold 2 h after ICV injection, and transiently increased the plasma concentration and liver content of IGF-I (60% and 90%, respectively) 30 min after ICV injection. M6G did not produce any significant alterations in plasma GH and IGF-I levels at the time-points measured. Both MOR and M6G increased the concentration of IGF binding protein-1 (IGFBP-1) in plasma and liver 2 h after injection. However, MOR showed 2- to 2.5-fold greater effect than M6G in stimulating plasma and liver IGFBP-1. MOR and M6G produced similar increases in plasma epinephrine (5-fold), norepinephrine (3-fold) and corticosterone (1.5-fold). Neither opiate significantly altered circulating insulin levels. These findings suggest that opiate modulation of GH and IGF may be hormone-independent and centrally modulated. We speculate that differential affinities of MOR and M6G to the different opiate receptor subtypes might be responsible for their distinct effects on GH/IGF-I system.

Original languageEnglish (US)
Pages (from-to)99-104
Number of pages6
JournalBrain Research Bulletin
Volume40
Issue number2
DOIs
StatePublished - Jan 1 1996

Fingerprint

Opiate Alkaloids
Insulin-Like Growth Factor I
Growth Hormone
Insulin-Like Growth Factor Binding Protein 1
Somatomedins
Injections
Liver
Opioid Receptors
Corticosterone
Morphine
Epinephrine
Norepinephrine
Hormones
Insulin

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

Hashiguchi, Yojiro ; Molina, Patricia E. ; Fan, Jie ; Lang, Charles H. ; Abumrad, Naji N. / Central opiate modulation of growth hormone and insulin-like growth factor-I. In: Brain Research Bulletin. 1996 ; Vol. 40, No. 2. pp. 99-104.
@article{187eb723684f47ddbb91e52d0022b303,
title = "Central opiate modulation of growth hormone and insulin-like growth factor-I",
abstract = "The effects of central administration of morphine-sulfate (MOR:80 μg) and morphine-6-glucuronide (M6G:1 μg) on the growth hormone (GH)/insulin-like growth factor (IGF) system were assessed. MOR and M6G were injected intracerebroventricularly (ICV) in chronically catheterized 24 h fasted rats; time-matched control animals received H2O (5 μl). MOR increased plasma GH concentrations 3-fold 2 h after ICV injection, and transiently increased the plasma concentration and liver content of IGF-I (60{\%} and 90{\%}, respectively) 30 min after ICV injection. M6G did not produce any significant alterations in plasma GH and IGF-I levels at the time-points measured. Both MOR and M6G increased the concentration of IGF binding protein-1 (IGFBP-1) in plasma and liver 2 h after injection. However, MOR showed 2- to 2.5-fold greater effect than M6G in stimulating plasma and liver IGFBP-1. MOR and M6G produced similar increases in plasma epinephrine (5-fold), norepinephrine (3-fold) and corticosterone (1.5-fold). Neither opiate significantly altered circulating insulin levels. These findings suggest that opiate modulation of GH and IGF may be hormone-independent and centrally modulated. We speculate that differential affinities of MOR and M6G to the different opiate receptor subtypes might be responsible for their distinct effects on GH/IGF-I system.",
author = "Yojiro Hashiguchi and Molina, {Patricia E.} and Jie Fan and Lang, {Charles H.} and Abumrad, {Naji N.}",
year = "1996",
month = "1",
day = "1",
doi = "10.1016/0361-9230(96)00045-7",
language = "English (US)",
volume = "40",
pages = "99--104",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",
number = "2",

}

Central opiate modulation of growth hormone and insulin-like growth factor-I. / Hashiguchi, Yojiro; Molina, Patricia E.; Fan, Jie; Lang, Charles H.; Abumrad, Naji N.

In: Brain Research Bulletin, Vol. 40, No. 2, 01.01.1996, p. 99-104.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Central opiate modulation of growth hormone and insulin-like growth factor-I

AU - Hashiguchi, Yojiro

AU - Molina, Patricia E.

AU - Fan, Jie

AU - Lang, Charles H.

AU - Abumrad, Naji N.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - The effects of central administration of morphine-sulfate (MOR:80 μg) and morphine-6-glucuronide (M6G:1 μg) on the growth hormone (GH)/insulin-like growth factor (IGF) system were assessed. MOR and M6G were injected intracerebroventricularly (ICV) in chronically catheterized 24 h fasted rats; time-matched control animals received H2O (5 μl). MOR increased plasma GH concentrations 3-fold 2 h after ICV injection, and transiently increased the plasma concentration and liver content of IGF-I (60% and 90%, respectively) 30 min after ICV injection. M6G did not produce any significant alterations in plasma GH and IGF-I levels at the time-points measured. Both MOR and M6G increased the concentration of IGF binding protein-1 (IGFBP-1) in plasma and liver 2 h after injection. However, MOR showed 2- to 2.5-fold greater effect than M6G in stimulating plasma and liver IGFBP-1. MOR and M6G produced similar increases in plasma epinephrine (5-fold), norepinephrine (3-fold) and corticosterone (1.5-fold). Neither opiate significantly altered circulating insulin levels. These findings suggest that opiate modulation of GH and IGF may be hormone-independent and centrally modulated. We speculate that differential affinities of MOR and M6G to the different opiate receptor subtypes might be responsible for their distinct effects on GH/IGF-I system.

AB - The effects of central administration of morphine-sulfate (MOR:80 μg) and morphine-6-glucuronide (M6G:1 μg) on the growth hormone (GH)/insulin-like growth factor (IGF) system were assessed. MOR and M6G were injected intracerebroventricularly (ICV) in chronically catheterized 24 h fasted rats; time-matched control animals received H2O (5 μl). MOR increased plasma GH concentrations 3-fold 2 h after ICV injection, and transiently increased the plasma concentration and liver content of IGF-I (60% and 90%, respectively) 30 min after ICV injection. M6G did not produce any significant alterations in plasma GH and IGF-I levels at the time-points measured. Both MOR and M6G increased the concentration of IGF binding protein-1 (IGFBP-1) in plasma and liver 2 h after injection. However, MOR showed 2- to 2.5-fold greater effect than M6G in stimulating plasma and liver IGFBP-1. MOR and M6G produced similar increases in plasma epinephrine (5-fold), norepinephrine (3-fold) and corticosterone (1.5-fold). Neither opiate significantly altered circulating insulin levels. These findings suggest that opiate modulation of GH and IGF may be hormone-independent and centrally modulated. We speculate that differential affinities of MOR and M6G to the different opiate receptor subtypes might be responsible for their distinct effects on GH/IGF-I system.

UR - http://www.scopus.com/inward/record.url?scp=0029996870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029996870&partnerID=8YFLogxK

U2 - 10.1016/0361-9230(96)00045-7

DO - 10.1016/0361-9230(96)00045-7

M3 - Article

VL - 40

SP - 99

EP - 104

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

IS - 2

ER -